Literature DB >> 15066190

Determinants of interferon-stimulated gene induction by RNAi vectors.

Stephanie Pebernard1, Richard D Iggo.   

Abstract

RNA interference is widely used to silence gene expression in mammalian cells. We recently reported that an shRNA expressed from the H1 promoter in a lentiviral vector could induce the expression of a large group of interferon-stimulated genes (ISGs). This response was unrelated to silencing of the gene targeted by the shRNA MORF4L1. In parallel, we constructed lentiviral vectors expressing shRNA from the U6 promoter and found that these too could induce expression of OAS1, a classic interferon target gene. The U6 vectors give a higher frequency of ISG induction than comparable lentiviral H1 vectors, suggesting that there might be a fundamental flaw in the vector design. We have characterized the U6 vectors in detail and report here that ISG induction is a consequence of the presence of an AA di-nucleotide near the transcription start site. A single nucleotide deletion in the siRNA sequence abolished OAS1 induction, suggesting that the mechanism underlying the response uses a sensor that can detect 19 bp RNA duplexes but not 14 bp duplexes. Adenoviral VA RNA I, which inhibits dsRNA-dependent protein kinase (PKR), was tested as a fusion partner to express shRNA on the grounds that it might prevent nonspecific off-target effects. Fusion of VA RNA I to a lamin shRNA was moderately effective in silencing lamin expression, but gave strong OAS1 induction by an shRNA that does not induce OAS1 when expressed from the U6 or H1 promoters. To avoid interferon induction by U6 vectors, we recommend preserving the wild-type sequence around the transcription start site, in particular a C/G sequence at positions -1/+1, and we describe a simple cloning strategy using the Gateway recombination system that facilitates this task.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15066190     DOI: 10.1111/j.1432-0436.2004.07202001.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  49 in total

1.  Functional characterization of the SOFA delta ribozyme.

Authors:  Lucien Junior Bergeron; Cédric Reymond; Jean-Pierre Perreault
Journal:  RNA       Date:  2005-10-26       Impact factor: 4.942

Review 2.  RNA interference in biology and disease.

Authors:  Carol A Sledz; Bryan R G Williams
Journal:  Blood       Date:  2005-04-12       Impact factor: 22.113

Review 3.  Silence of the transcripts: RNA interference in medicine.

Authors:  Sailen Barik
Journal:  J Mol Med (Berl)       Date:  2005-07-19       Impact factor: 4.599

4.  Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors.

Authors:  Dong Sung An; F Xiao-Feng Qin; Vincent C Auyeung; Si Hua Mao; Sam K P Kung; David Baltimore; Irvin S Y Chen
Journal:  Mol Ther       Date:  2006-07-17       Impact factor: 11.454

Review 5.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

6.  Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model.

Authors:  S M Eck; P J Hoopes; B L Petrella; C I Coon; C E Brinckerhoff
Journal:  Breast Cancer Res Treat       Date:  2008-07-03       Impact factor: 4.872

7.  Down-regulation of p53 by double-stranded RNA modulates the antiviral response.

Authors:  Joao T Marques; Dominique Rebouillat; Chilakamarti V Ramana; Junko Murakami; Jason E Hill; Andrei Gudkov; Robert H Silverman; George R Stark; Bryan R G Williams
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus.

Authors:  Srikanth Kota; Ahmed Sabbah; Te Hung Chang; Rosalinda Harnack; Yan Xiang; Xiangzhi Meng; Santanu Bose
Journal:  J Biol Chem       Date:  2008-06-20       Impact factor: 5.157

9.  Therapeutic potential of RNA interference in pain medicine.

Authors:  Ping-Heng Tan; Lin-Cheng Yang; Ru-Rong Ji
Journal:  Open Pain J       Date:  2009-01-01

10.  Short-hairpin RNAs delivered by lentiviral vector transduction trigger RIG-I-mediated IFN activation.

Authors:  Rachael Kenworthy; Diana Lambert; Feng Yang; Nan Wang; Zihong Chen; Haizhen Zhu; Fanxiu Zhu; Chen Liu; Kui Li; Hengli Tang
Journal:  Nucleic Acids Res       Date:  2009-09-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.